Your browser doesn't support javascript.
loading
Enhanced anticancer effect of MAP30-S3 by cyclosproin A through endosomal escape.
Song, Zhen-Tao; Zhang, Leshuai W; Fan, Li-Qiang; Kong, Jing-Wen; Mao, Jun-Hua; Zhao, Jian; Wang, Fu-Jun.
Afiliação
  • Song ZT; State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology.
  • Zhang LW; School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou.
  • Fan LQ; Zhejiang Reachall Pharmaceutical Co. Ltd, Dongyang, China.
  • Kong JW; State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology.
  • Mao JH; State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology.
  • Zhao J; Zhejiang Reachall Pharmaceutical Co. Ltd, Dongyang, China.
  • Wang FJ; State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology.
Anticancer Drugs ; 29(8): 736-747, 2018 09.
Article em En | MEDLINE | ID: mdl-29912010
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Endossomos / Proteínas Ribossômicas / Proteínas Recombinantes de Fusão / Ciclosporina / Proteínas Inativadoras de Ribossomos Tipo 2 / Neoplasias Limite: Humans Idioma: En Revista: Anticancer Drugs Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Endossomos / Proteínas Ribossômicas / Proteínas Recombinantes de Fusão / Ciclosporina / Proteínas Inativadoras de Ribossomos Tipo 2 / Neoplasias Limite: Humans Idioma: En Revista: Anticancer Drugs Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2018 Tipo de documento: Article